Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T17:08:40.426Z.
Calculation as of: 2026-10-06T17:08:40.426Z.
Quote observation: 2026-10-06T17:02:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8b72fc44080d8c671fb5883057af471201fb64a542d8aebba0fac2689ec384f4
PE RATIO
N/A
Market Cap
$874437.00
PE Ratio
N/A
TTM Avg
123162.46
3Y Avg
123162.46
5Y Avg
123162.46
Market Cap
$1.02M
PE Ratio
N/A
TTM Avg
173046.93
3Y Avg
281427.36
5Y Avg
281427.36
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sunshine Biopharma, Inc. (SBFM) | $880215.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A | N/A | N/A | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $874437.00 | N/A | 123162.46 | 123162.46 | 123162.46 |
| Decoy Therapeutics Inc. (DCOY)vs › | $851149.00 | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $859749.00 | N/A | 0.00 | 0.00 | 0.00 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $842981.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $791587.00 | N/A | 0.43 | 0.43 | 0.34 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | N/A | 173046.93 | 281427.36 | 281427.36 |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $674156.00 | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$0.37
Forward EPS (Est.)
$-1.95
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
